Phase I, open-label study of pasireotide in patients with...

ESMO Open 2018 / 07 Vol. 3; Iss. 5

Phase I, open-label study of pasireotide in patients with BRAF- wild type and NRAS -wild type, unresectable and/or metastatic melanoma

Dummer, Reinhard, Michielin, Olivier, Nägeli, Mirjam Chantal, M. Goldinger, Simone, Campigotto, Federico, Kriemler-Krahn, Ulrike, Schmid, Herbert, Pedroncelli, Alberto, Micaletto, Sara, Schadendorf, D
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
3
Language:
english
Journal:
ESMO Open
DOI:
10.1136/esmoopen-2018-000388
Date:
July, 2018
File:
PDF, 1.23 MB
english, 2018
Conversion to is in progress
Conversion to is failed